Tara McCready

发表

Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus.

S. Yusuf, G. Dagenais, F. McAlister, 2010, The Canadian journal of cardiology.

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.

V. Fuster, P. López-Jaramillo, K. Yusoff, 2017, Cardiology clinics.

Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study.

S. Yusuf, P. López-Jaramillo, K. Yusoff, 2018, American heart journal.

Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series Study (Preprint)

J. Grimshaw, M. Taljaard, N. Ivers, 2020 .

Health-Related Quality of Life and Mortality in Heart Failure

S. Yusuf, P. López-Jaramillo, A. Dans, 2021, Circulation.

Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group

S. Yusuf, J. Pogue, J. Cairns, 2011, Trials.

Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series study

J. Grimshaw, M. Taljaard, N. Ivers, 2022, BMC Medicine.

Polypill for cardiovascular disease prevention--reply.

S. Yusuf, Richard Smith, Tara McCready, 2013, JAMA.

Morbidity and mortality after recognition of macroalbuminuria in Pasi ﬁ ka people with type 2 diabetes in a primary health-care practice

T. Cundy, Tara McCready, Glenn Doherty, 2021 .

Factors associated with health‐related quality of life in heart failure in 23 000 patients from 40 countries: results of the G‐CHF research programme

S. Yusuf, Jun Zhu, K. Sliwa, 2022, European journal of heart failure.

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.

S. Yusuf, Jun Zhu, A. Roy, 2022, The Lancet. Global health.

Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.

S. Yusuf, J. Bosch, D. Xavier, 2013, European heart journal.

Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach

S. Yusuf, K. Yusoff, M. Mckee, 2015, BMC Health Services Research.

Patients’ Knowledge, Attitudes, Behaviour and Health Care Experiences on the Prevention, Detection, Management and Control of Hypertension in Colombia: A Qualitative Study

S. Yusuf, P. López-Jaramillo, M. Mckee, 2015, PloS one.

A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry.

S. Yusuf, Jun Zhu, K. Sliwa, 2020, American heart journal.

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial

S. Yusuf, P. López-Jaramillo, K. Yusoff, 2019, The Lancet.

Polypill with or without Aspirin in Persons without Cardiovascular Disease.

S. Yusuf, J. Bosch, G. Dagenais, 2020, The New England journal of medicine.

Could patents interfere with the development of a cardiovascular polypill?

S. Yusuf, M. Huffman, A. Attaran, 2016, Journal of Translational Medicine.

Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial

J. Grimshaw, M. Taljaard, H. Witteman, 2020, BMJ.

Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series Study

J. Grimshaw, M. Taljaard, N. Ivers, 2020, JMIR research protocols.

Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease

S. Yusuf, P. López-Jaramillo, K. Yusoff, 2018, Global heart.

Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study

S. Yusuf, M. Mckee, A. Attaran, 2020, CJC open.

Interventions Supporting Long‐term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol

J. Tu, J. Grimshaw, M. Taljaard, 2017, American heart journal.

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.

E. Lonn, S. Mehta, G. Paré, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A machine learning–based clinical decision support algorithm for reducing unnecessary coronary angiograms

T. Sheth, Tara McCready, M. Natarajan, 2021, Cardiovascular digital health journal.

Global Variations in Heart Failure Etiology, Management, and Outcomes.

S. Yusuf, Jun Zhu, P. López-Jaramillo, 2023, JAMA.

Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program

K. Yusoff, Jérôme Casas, G. Bloomfield, 2017, Globalization and Health.

Could patents interfere with the development of a cardiovascular polypill?

Mark D. Huffman, S. Yusuf, M. Huffman, 2016, Journal of Translational Medicine.

Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.

J. Bosch, P. Pais, E. Lonn, 2013, European Heart Journal.

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.

V. Fuster, P. López-Jaramillo, K. Yusoff, 2017, Cardiology clinics.

Combination therapy to prevent cardiovascular disease: slow progress.

S. Yusuf, Tara McCready, Richard J. H. Smith, 2013, JAMA.

Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 Intervention

S. Islam, Tara McCready, Salim Yusuf, 2024, Circulation. Cardiovascular Quality and Outcomes.

Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries

G. C. Sharma, S. Yusuf, P. López-Jaramillo, 2023, European heart journal.